. "P\u0159\u00EDznaky doln\u00EDch mo\u010Dov\u00FDch cest v d\u016Fsledku neurogenn\u00ED dysfunkce doln\u00EDch cest mo\u010Dov\u00FDch (NDMC) pat\u0159\u00ED mezi symptomy, kter\u00E9 nejv\u00EDce obt\u011B\u017Euj\u00ED pacienty s roztrou\u0161enou skler\u00F3zou (RS). Pokud nejsou l\u00E9\u010Deny spr\u00E1vn\u011B, mohou zp\u016Fsobit ireverzibiln\u00ED zm\u011Bny doln\u00EDch i horn\u00EDch mo\u010Dov\u00FDch cest. NDMC mohou tak\u00E9 zhor\u0161it pr\u016Fb\u011Bh samotn\u00E9 RS a t\u00EDm i celkov\u00E9ho zdravotn\u00EDho posti\u017Een\u00ED. Sou\u010Dasn\u00E9 doporu\u010Den\u00ED vytvo\u0159en\u00E9 ICS a EAU pro sledov\u00E1n\u00ED pacient\u016F s NDMC je koncipov\u00E1no pouze obecn\u011B pro pacienty posti\u017Een\u00E9 jak\u00FDmkoli neurologick\u00FDm posti\u017Een\u00EDm, ne v\u0161ak pro pacienty s RS. Na\u0161e klinick\u00E9 pozorov\u00E1n\u00ED nazna\u010Dovalo zhor\u0161ov\u00E1n\u00ED NDMC u pacient\u016F s RS v n\u00E1vaznosti na dynamickou progresi demyeliniza\u010Dn\u00EDho onemocn\u011Bn\u00ED. C\u00EDlem prospektivn\u00ED kontrolovan\u00E9 studie bylo zhodnotit parametry urodynamick\u00E9ho vy\u0161et\u0159en\u00ED u pacient\u016F s RS v \u010Dasov\u00E9 ose a vytvo\u0159it p\u0159\u00EDpadn\u011B doporu\u010Den\u00ED dispenzarizace pro klinickou praxi."@cs . "RIV/00216224:14110/14:00078505!RIV15-MSM-14110___" . "11"^^ . . "Je pot\u0159eba stanovit frekvenci urodynamick\u00E9ho vy\u0161et\u0159en\u00ED u pacient\u016F posti\u017Een\u00FDch dysfunkc\u00ED doln\u00EDch mo\u010Dov\u00FDch cest v d\u016Fsledku roztrou\u0161en\u00E9 skler\u00F3zy?"@cs . "P\u0159\u00EDznaky doln\u00EDch mo\u010Dov\u00FDch cest v d\u016Fsledku neurogenn\u00ED dysfunkce doln\u00EDch cest mo\u010Dov\u00FDch (NDMC) pat\u0159\u00ED mezi symptomy, kter\u00E9 nejv\u00EDce obt\u011B\u017Euj\u00ED pacienty s roztrou\u0161enou skler\u00F3zou (RS). Pokud nejsou l\u00E9\u010Deny spr\u00E1vn\u011B, mohou zp\u016Fsobit ireverzibiln\u00ED zm\u011Bny doln\u00EDch i horn\u00EDch mo\u010Dov\u00FDch cest. NDMC mohou tak\u00E9 zhor\u0161it pr\u016Fb\u011Bh samotn\u00E9 RS a t\u00EDm i celkov\u00E9ho zdravotn\u00EDho posti\u017Een\u00ED. Sou\u010Dasn\u00E9 doporu\u010Den\u00ED vytvo\u0159en\u00E9 ICS a EAU pro sledov\u00E1n\u00ED pacient\u016F s NDMC je koncipov\u00E1no pouze obecn\u011B pro pacienty posti\u017Een\u00E9 jak\u00FDmkoli neurologick\u00FDm posti\u017Een\u00EDm, ne v\u0161ak pro pacienty s RS. Na\u0161e klinick\u00E9 pozorov\u00E1n\u00ED nazna\u010Dovalo zhor\u0161ov\u00E1n\u00ED NDMC u pacient\u016F s RS v n\u00E1vaznosti na dynamickou progresi demyeliniza\u010Dn\u00EDho onemocn\u011Bn\u00ED. C\u00EDlem prospektivn\u00ED kontrolovan\u00E9 studie bylo zhodnotit parametry urodynamick\u00E9ho vy\u0161et\u0159en\u00ED u pacient\u016F s RS v \u010Dasov\u00E9 ose a vytvo\u0159it p\u0159\u00EDpadn\u011B doporu\u010Den\u00ED dispenzarizace pro klinickou praxi." . . . . "14110" . "Je pot\u0159eba stanovit frekvenci urodynamick\u00E9ho vy\u0161et\u0159en\u00ED u pacient\u016F posti\u017Een\u00FDch dysfunkc\u00ED doln\u00EDch mo\u010Dov\u00FDch cest v d\u016Fsledku roztrou\u0161en\u00E9 skler\u00F3zy?" . . "Urologick\u00E9 listy" . . . "12" . "Varga, Gabriel" . "1214-2085" . "IS IT NECESSARY TO DETERMINE THE FREQUENCY OF URODYNAMICS IN PATIENTS SUFFERING FROM LOWER URINARY TRACT DYSFUNCTION DUE TO MULTIPLE SCLEROSIS?"@en . . "RIV/00216224:14110/14:00078505" . "6"^^ . "I" . "urodynamics; neurogenic lower urinary tract dysfunction; multiple sclerosis"@en . "IS IT NECESSARY TO DETERMINE THE FREQUENCY OF URODYNAMICS IN PATIENTS SUFFERING FROM LOWER URINARY TRACT DYSFUNCTION DUE TO MULTIPLE SCLEROSIS?"@en . . "Wasserbauer, Roman" . "Pac\u00EDk, Dalibor" . "Praksov\u00E1, Petra" . "6"^^ . "Pavl\u00EDk, Tom\u00E1\u0161" . . "Lower urinary tract symptoms due to neurogenic dysfunction of the lower urinary tract (NDLUT) belong to symptoms that most often bother patients with multiple sclerosis (MS). If not treated properly, can lead to irreversible changes of the lower and upper urinary tract. NDLUT may also worsen the course of MS and general health disability. Current recommendations generated by ICS and EAU for monitoring patients with NDLUT are generally designed for patients with any neurological disabilities, but not for patients with MS. Our clinical observations indicate worsening of NDLUT in patients with MS in relation to the dynamic progression of the demyelinating disease. The aim of this prospective controlled study was to evaluate the parameters of urodynamic examinations in patients with MS in the timeline and create a recommendations for clinical practice."@en . "Je pot\u0159eba stanovit frekvenci urodynamick\u00E9ho vy\u0161et\u0159en\u00ED u pacient\u016F posti\u017Een\u00FDch dysfunkc\u00ED doln\u00EDch mo\u010Dov\u00FDch cest v d\u016Fsledku roztrou\u0161en\u00E9 skler\u00F3zy?"@cs . . . "Janou\u0161ov\u00E1, Eva" . . . "3" . . . "Je pot\u0159eba stanovit frekvenci urodynamick\u00E9ho vy\u0161et\u0159en\u00ED u pacient\u016F posti\u017Een\u00FDch dysfunkc\u00ED doln\u00EDch mo\u010Dov\u00FDch cest v d\u016Fsledku roztrou\u0161en\u00E9 skler\u00F3zy?" . "23355" . . . "CZ - \u010Cesk\u00E1 republika" . "[3396A4E251E7]" .